Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...

The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...

The progression of evidence has marched forward from studies showing a reduction in salt associated with lower blood pressure ...

Spanish scientists have produced a report on the growth of Clostridium botulinum and the risk of botulism following an ...

Kansas food safety and lodging inspectors cited nine Topeka establishments for non-compliance with state law in January. Here ...

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

Textile Testing Market is Segmented by Type (Chemical Testing, Performance Testing, Packaging Testing), by Application ...

US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy: Tokyo Friday, February 14, 2025, 09:00 Hrs [IST] Astellas Pharma Inc., a global lif ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAY™ ...

The Food and Drug Administration (FDA) has expanded the labeling for Izervay™ (avacincaptad pegol intravitreal solution) to include longer-term ...

Baby gates sold exclusively on Amazon have been recalled over a potential entrapment risk for children, according to the U.S.

Astria advances innovative therapies for hereditary angioedema and atopic dermatitis. Strong cash position supports pivotal ...